A complete application in a minute — tailored resume and cover letter, ready to send.
PharmaEssentia USA Corporation is seeking an experienced Associate Director, Investor Relations in Burlington, MA. This role will enhance U.S. investor engagement and translate scientific priorities into a clear investment narrative.
You will partner with senior leadership and multiple teams to manage investor relations, earnings prep, and public disclosures, in a hybrid work setting.
Location: Burlington, MA (hybrid)
It’s not often you get the chance to make a real impact on the lives of others, while expanding your own possibilities. You’ll find that rare opportunity at PharmaEssentia USA Corporation (PEC). Join us, and let’s transform lives, together.
PharmaEssentia USAis a rapidly growing biopharmaceutical innovator. We are leveraging deep expertise and proven scientific principles to deliver effective new biologics for challenging diseases in the areas of hematology and oncology, with one product approved in the United Statesand a diversifying pipeline. We believe in the potential to improve both health and quality of life for patients with limited options today through the combination of rigorous research and innovative thinking.
Founded in 2003 by a team of Taiwanese-American executives and renowned scientists from U.S. biotechnology and pharmaceutical companies, today we are listed on the Taipei Exchange (6446) and are expanding our global presence with operations in the U.S., Japan, South Korea and China, along with a world-class biologics production facility in Taichung.
We are seeking an experienced Associate Director, Investor Relations to help build and execute PharmaEssentia’s U.S. investor relations capability. This role will strengthen engagement with the global investment community, expand awareness among U.S. healthcare investors, and translate the company’s scientific, clinical, commercial, and strategic priorities into a clear investment narrative.
The Associate Director will serve as a key liaison with current and prospective institutional investors, sell-side analysts, investment banks, and other capital markets stakeholders. The role requires close partnership with senior leadership and teams across Corporate Strategy, Corporate Communications, Finance, Commercial, Medical Affairs, R&D, Legal, and other functions.
The expected salary range for this position based on greater Boston, MA location is $157,080-204,000. Actual salary pay will be based on multiple factors, including geographic location, experience, qualifications, and other job-related factors permitted by law.
At PharmaEssentia USA, we are committed to providing an environment of mutual respect where equal employment opportunities are available to all applicants without regard to race, color, religion, sex, pregnancy (including childbirth and related medical conditions), national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information (including characteristics and testing), military and veteran status, and any other characteristic protected by applicable law. PharmaEssentia USA believes that diversity and inclusion among our team are critical to our success as a global company, and we seek to recruit, develop and retain the most talented people from a diverse candidate pool.
PharmaEssentia does not accept unsolicited agency resumes. Staffing agencies should not send resumes to our HR team or to any PharmaEssentia employees. PharmaEssentia is not responsible for any fees related to unsolicited resumes from staffing agencies.
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
At PharmaEssentia, our goal is to treat as many people with cancer as possible. That means challenging the status quo with better science that leads to better lives. By joining our team, you will not only expand your own possibilities, but you will contribute to expanding options for people with cancer.